PreHevbri 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification1 
Decision 
Information 
issued on 
Issued2 / 
affected3  
IB/0008 
B.II.e.5.a.2 - Change in pack size of the finished 
21/12/2023 
product - Change in the number of units (e.g. 
tablets, ampoules, etc.) in a pack - Change outside 
the range of the currently approved pack sizes 
amended 
on 
SmPC, 
Labelling and 
PL 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
IB/0007 
B.II.f.1.b.5 - Stability of FP - Extension of the shelf 
06/11/2023 
SmPC 
life of the finished product - Biological/immunological 
medicinal product in accordance with an approved 
stability protocol 
II/0006 
B.I.a.2.c - Changes in the manufacturing process of 
12/10/2023 
n/a 
the AS - The change refers to a [-] substance in the 
manufacture of a biological/immunological substance 
which may have a significant impact on the medicinal 
product and is not related to a protocol 
IA/0005 
B.II.c.1.a - Change in the specification parameters 
13/04/2023 
n/a 
and/or limits of an excipient - Tightening of 
specification limits 
IB/0004 
B.II.b.3.a - Change in the manufacturing process of 
12/04/2023 
n/a 
the finished or intermediate product - Minor change 
in the manufacturing process 
IAIN/0003 
A.5.a - Administrative change - Change in the name 
17/03/2023 
and/or address of a manufacturer/importer 
responsible for batch release 
Annex II and 
PL 
IA/0002/G 
This was an application for a group of variations. 
14/12/2022 
n/a 
A.7 - Administrative change - Deletion of 
manufacturing sites 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.II.c.1.c - Change in the specification parameters 
Page 2/3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and/or limits of an excipient - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
B.II.e.2.c - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Deletion of a non-significant 
specification parameter (e.g. deletion of an obsolete 
parameter) 
IB/0001 
B.I.a.4.z - Change to in-process tests or limits 
17/08/2022 
n/a 
applied during the manufacture of the AS - Other 
variation 
Page 3/3 
 
 
 
 
 
 
 
 
 
 
